ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,148,343 | +18.8% | 1,171,779 | +68.5% | 0.34% | +26.3% |
| Q2 2023 | $966,470 | +324.0% | 695,302 | +385.0% | 0.27% | +285.7% |
| Q1 2023 | $227,946 | -92.2% | 143,362 | -69.5% | 0.07% | -92.1% |
| Q4 2022 | $2,928,723 | +68.1% | 470,100 | +80.8% | 0.88% | +32.3% |
| Q3 2022 | $1,742,000 | +58.8% | 260,000 | +50.7% | 0.67% | +39.7% |
| Q2 2022 | $1,097,000 | -43.6% | 172,500 | -58.9% | 0.48% | -38.0% |
| Q1 2022 | $1,945,000 | -22.2% | 419,262 | -16.1% | 0.77% | +24.0% |
| Q4 2021 | $2,500,000 | – | 500,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |